Influenza Trials in Cincinnati, United States
Conditions / Influenza / Cincinnati, United States
Research into Influenza spans multiple therapeutic approaches and trial phases.
83 total trials for this combination
Showing top 10 of 83 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00419263 | Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza. | COMPLETED | PHASE2 |
| NCT00412737 | A Study of Oseltamivir (Tamiflu) for the Seasonal Prophylaxis of Influenza in Immunocompromised Participants | COMPLETED | PHASE4 |
| NCT01032837 | A Study of Tamiflu (Oseltamivir) for Treatment of Influenza With a Focus on (H1N1) 2009 Flu Strain | TERMINATED | PHASE4 |
| NCT06097273 | A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age | COMPLETED | PHASE3 |
| NCT06178991 | A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza. | COMPLETED | PHASE3 |
| NCT03600428 | Safety of LAIV4 in Children With Asthma | COMPLETED | PHASE4 |
| NCT07159763 | A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03969212 | Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A or B in Households | COMPLETED | PHASE3 |
| NCT01050257 | A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza | COMPLETED | PHASE3 |
| NCT00128167 | Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6-59 Months of Age | COMPLETED | PHASE3 |